Ascentage Pharma to Present Four Promising Preclinical Studies Demonstrating the Potential of Combination Therapies at American Association for Cancer Research (A…

Olverembatinib, an investigational multikinase inhibitor (approved in China for CML), inhibits Src-family kinases (e.g., Lyn, ...

A light-controlled 'muscle' could give synthetic cells a new way to move

Engineers interested in creating artificial cells to deliver drugs to unhealthy parts of the body face a key challenge: for a ...
News-Medical.Net

Yeast model reveals mechanisms behind premature aging from progerin

A new research paper was published in Volume 18 of Aging-US on April 3, 2026, titled "Modeling premature aging in yeast via ...
Le Lézard

EpiBiologics Doses First Patient with EPI-326 Bispecific Antibody in Global Phase 1 Study for EGFR-Driven Solid Tumors

EpiBiologics, a leader in tissue-selective extracellular protein degradation, today announced that the first patient has been dosed with EPI-326 in its global Phase 1 clinical study. EPI-326 is the ...